Sympathomimetic bronchodilators: increased selectivity with lung-specific prodrugs.
- 1 January 1985
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 2 (4) , 156-162
- https://doi.org/10.1023/A:1016379820412
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Mechanisms of Membrane-Receptor RegulationNew England Journal of Medicine, 1984
- Two New ?2-Adrenoceptor Agonists, D-2343 and QH 25, Studied in Asthmatic PatientsAllergy, 1982
- Prodrug designPharmacology & Therapeutics, 1981
- Inhibitory Effect of KWD 2131, Terbutaline, and DSCG on the Immediate and Late Allergen-Induced BronchoconstrictionAllergy, 1981
- Anti-Anaphylactic and Bronchodilating Action of a Beta-Adrenoceptor Stimulator, KWD 2131, in Human Lung TissueAllergy, 1979
- Circulatory Effects of β2‐Receptor Agonists in ManActa Pharmacologica et Toxicologica, 1979
- HexoprenalineDrugs, 1977
- Rationale for Design of Biologically Reversible Drug Derivatives: ProdrugsJournal of Pharmaceutical Sciences, 1975
- Two new groups of selective stimulants of adrenergicβ-receptorsCellular and Molecular Life Sciences, 1969
- Differentiation of Receptor Systems activated by Sympathomimetic AminesNature, 1967